C. De Giovanni

发表

Delivery of CD44 shRNA/Nanoparticles within Cancer Cells

Roger R Markwald, Vincent C Hascall, R. Markwald, 2009, Journal of Biological Chemistry.

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

F. Pappalardo, S. Motta, P. Lollini, 2010, Cancer research.

The prospects for cancer gene therapy.

G. Forni, P. Nanni, C. De Giovanni, 2000, International journal of immunopharmacology.

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis

G. Benegiamo, P. Lollini, M. Iezzi, 2015, Breast Cancer Research.

Preclinical HER-2 Vaccines: From Rodent to Human HER-2

P. Lollini, P. Nanni, C. De Giovanni, 2013, Front. Oncol..

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER‐2/neu transgenic mice

P. Musiani, P. Lollini, W. Muller, 1998, International journal of cancer.

Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA).

P. Lollini, K. Scotlandi, P. Nanni, 1989, Anticancer research.

Immunological Prevention of a Multigene Cancer Syndrome

P. Musiani, P. Lollini, G. Forni, 2004, Cancer Research.

Prevention of HER‐2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12

P. Musiani, P. Lollini, G. Forni, 2003, International journal of cancer.

Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER‐2/neu oncogene‐driven animal model system

K. Shin‐ya, B. Seliger, P. Lollini, 2010, Proteomics.

Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus

P. Lollini, M. Iezzi, P. Nanni, 2013, PLoS pathogens.

Rethinking herpes simplex virus: the way to oncolytic agents

P. Lollini, P. Nanni, C. De Giovanni, 2011, Reviews in medical virology.

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy

P. Lollini, P. Nanni, C. De Giovanni, 2021, Cells.

p185neu protein is required for tumor and anchorage‐independent growth, not for cell proliferation of transgenic mammary carcinoma

S. Ménard, P. Musiani, P. Lollini, 2000, International journal of cancer.

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

P. Lollini, D. Santini, M. Arigoni, 2021, Scientific Reports.

Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.

P. Lollini, P. Comoglio, G. Basso, 1996, Oncogene.

Immunoprevention and Immunotherapy of Mammary Carcinoma

P. Lollini, P. Nanni, C. De Giovanni, 2010, The breast journal.

HER/erbB Receptors as Therapeutic Targets of Immunotoxins in Human Rhabdomyosarcoma Cells

L. Polito, A. Bolognesi, P. Lollini, 2002, Journal of immunotherapy.

Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice.

S. Morrison, M. Penichet, G. Forni, 2003, Vaccine.

Systemic effects of cytokines released by gene‐transduced tumor cells: Marked hyperplasia induced in small bowel by γ‐interferon transfectants through host lymphocytes

P. Lollini, W. Grigioni, P. Nanni, 1995, International journal of cancer.

Expression of HER/erbb family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells

S. Ménard, P. Lollini, K. Scotlandi, 2000, International journal of cancer.

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

P. Lollini, M. Iezzi, P. Nanni, 2012, British Journal of Cancer.

Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

P. Musiani, A. Allione, A. Modesti, 1995, Journal of immunology.

Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells

P. Lollini, P. Nanni, C. De Giovanni, 2004, Cancer Research.

In vivo reexpression of H-2 antigens in B16 melanoma cells.

P. Lollini, M. Colombo, P. Nanni, 1985, Experimental and Clinical Immunogenetics.

Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.

P. Musiani, P. Lollini, M. Iezzi, 2003, Cancer research.

Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.

P. Lollini, G. Forni, P. Nanni, 1996, British Journal of Cancer.

APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivo.

I. Fong, K. Brown, A. Gescher, 2009, European journal of cancer.

Colony-stimulating activity from the new metastatic TS/A cell line and its high- and low-metastatic clonal derivatives.

P. Lollini, P. Brambilla, P. Nanni, 1985, British Journal of Cancer.

The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.

A. Rosato, P. Lollini, V. Tosello, 2003, Cancer research.

INTERLEUKIN 6 GENE‐TRANSFECTED MOUSE MAMMARY ADENOCARCINOMA: TUMOUR CELL GROWTH AND METASTATIC POTENTIAL

P. Musiani, A. Allione, A. Modesti, 1997, The Journal of pathology.

Gene transfer of a secretable form of IL‐15 in murine adenocarcinoma cells: Effects on tumorigenicity, metastatic potential and immune response

P. Musiani, M. Cilli, P. Lollini, 2000, International journal of cancer.

The occurrence of multiple steroid hormone receptors in disease‐free and neoplastic human ovary

S. Grilli, P. Nanni, C. De Giovanni, 1981, Cancer.

Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.

P. Lollini, P. Nanni, C. De Giovanni, 2007, Oncology reports.

Immunological and non‐immunological influence of H‐2Kb gene transfection on the metastatic ability of B16 melanoma cells

P. Lollini, P. Tazzari, A. Santoni, 1991, International journal of cancer.

Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.

E. Dejana, P. Lollini, E. Lalli, 1993, British Journal of Cancer.

Modulation by Ifn-Gamma of the Metastatic Ability of Murine, Human, and H-2-Transfected Tumor Cells

P. Lollini, K. Scotlandi, P. Nanni, 1989, Tumori.

Antimetastatic activity of a preventive cancer vaccine.

P. Musiani, P. Lollini, M. Iezzi, 2007, Cancer research.

Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 1993, British Journal of Cancer.

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.

P. Musiani, M. Penichet, P. Lollini, 2009, Human gene therapy.

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4

P. Lollini, P. Nanni, C. De Giovanni, 2009, Molecular Cancer Therapeutics.

Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role.

P. Lollini, P. Nanni, C. De Giovanni, 2006, European journal of cancer.

Production of stem cell factor and expression of c‐kit in human rhabdomyosarcoma cells: Lack of autocrine growth modulation

P. Lollini, P. Strippoli, P. Nanni, 1998, International journal of cancer.

Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 1996, Cancer research.

Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.

P. Lollini, M. Colombo, P. Nanni, 1995, British Journal of Cancer.

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

P. Lollini, C. García-echeverría, K. Scotlandi, 2010, European journal of cancer.

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

P. Lollini, M. Colombo, P. Nanni, 2018, Oncoimmunology.

Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase gene.

P. Lollini, P. Picci, D. Maurici, 2000, Bone.

Human rhabdomyosarcoma cells in nude mice as a model for metastasis and differentiation.

P. Lollini, K. Scotlandi, P. Nanni, 1989, Invasion & metastasis.

RMZ: a new cell line from a human alveolar rhabdomyosarcoma. In vitro expression of embryonic myosin.

P. Lollini, V. Eusebi, S. Schiaffino, 1986, British Journal of Cancer.

Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.

P. Lollini, K. Scotlandi, P. Nanni, 1989, Cancer research.

Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.

P. Musiani, P. Lollini, A. Modesti, 1993, International journal of cancer.

H‐2Kb AND H‐2Db gene transfections in B16 melanoma differently affect non‐immunological properties relevant to the metastatic process. Involvement of integrin molecules

P. Lollini, A. Santoni, P. Nanni, 1994, International journal of cancer.

Expression of interleukin 15 (IL‐15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma

P. Lollini, N. Baldini, A. Santoni, 1997, International journal of cancer.

2011: the immune hallmarks of cancer

Federica Cavallo, Patrizia Nanni, Guido Forni, 2011, Cancer Immunology, Immunotherapy.

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

P. Lollini, P. Nanni, C. De Giovanni, 2019, BMC Cancer.

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Ilaria Rossi, 1998, The Journal of experimental medicine.

Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia

M. Gobbi, P. Lollini, S. Grilli, 1982, Cancer.

In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.

P. Lollini, L. Tessarollo, G. Azzarello, 1991, British Journal of Cancer.

Clones with different metastatic capacity and variant selection during metastasis: a problematic relationship.

P. Lollini, P. Nanni, C. De Giovanni, 1986, Journal of the National Cancer Institute.

Different metastatic aggressiveness by murine TS/A clones: ultrastructure, extracellular glycoproteins and type IV collagenolytic activity.

P. Lollini, W. Grigioni, P. Nanni, 1988, Invasion & metastasis.

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model

P. Lollini, P. Nanni, C. De Giovanni, 2019, Cancers.

The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells.

P. Musiani, P. Lollini, G. Forni, 1998, Human gene therapy.

HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response.

P. Lollini, D. Santini, M. Iezzi, 2017, Oncotarget.

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins.

P. Lollini, G. Forni, M. Iezzi, 2010, Cancer research.

Concomitant amplification and expression of PAX7-FKHR and MYCN in a human rhabdomyosarcoma cell line carrying a cryptic t(1;13)(p36;q14).

B. Schafer, L. Brečević, P. Nanni, 2000, Cancer genetics and cytogenetics.

Preclinical vaccines against mammary carcinoma

P. Lollini, P. Nanni, C. De Giovanni, 2013, Expert review of vaccines.

Dral Is a P53-Responsive Gene Whose Four and a Half Lim Domain Protein Product Induces Apoptosis

B. Schäfer, E. Ehler, P. Mcloughlin, 2000, The Journal of cell biology.

Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells

M. Attimonelli, P. Lollini, V. Giorgio, 2013, Cancer & Metabolism.

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression

P. Lollini, M. Arigoni, R. Calogero, 2021, Oncogenesis.

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.

Piero Musiani, Remo Sanges, Federica Cavallo, 2004, The Journal of clinical investigation.

Heterogeneity and clonal interactions in the TS/A murine mammary adenocarcinoma.

P. Lollini, K. Scotlandi, P. Nanni, 1988, Advances in experimental medicine and biology.

Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene

P. Musiani, P. Lollini, G. Forni, 1993 .

New target antigens for cancer immunoprevention.

P. Lollini, P. Nanni, C. De Giovanni, 2005, Current cancer drug targets.

The simultaneous occurrence of cytoplasmic receptors for various steroid hormones in male breast carcinoma and gynaecomastia.

S. Grilli, P. Nanni, C. De Giovanni, 1980, Journal of steroid biochemistry.

Correlation between clinical response to antiandrogenic therapy and occurrence of receptors in human prostatic cancer.

S. Grilli, C. De Giovanni, G. Prodi, 1980, Urology.

Interleukin 12 gene therapy of MHC-negative murine melanoma metastases.

P. Lollini, M. Colombo, A. Stoppacciaro, 1998, Cancer research.

Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment.

P. Lollini, V. Giorgio, A. Porcelli, 2014, Human molecular genetics.

The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.

P. Lollini, K. Scotlandi, P. Nanni, 2000, The American journal of pathology.

In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding.

P. Lollini, G. Zauli, K. Scotlandi, 1989, European journal of cancer & clinical oncology.

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2

M. Penichet, P. Lollini, M. Iezzi, 2014, Breast Cancer Research.

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2001, The Journal of experimental medicine.

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

P. Lollini, P. Picci, P. Nanni, 2014, Oncotarget.

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 2001, Gene.

Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells.

P. Lollini, G. D’Orazi, S. Soddu, 1998, British Journal of Cancer.

Molecular and cellular biology of rhabdomyosarcoma.

P. Lollini, P. Nanni, C. De Giovanni, 2009, Future oncology.

Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells

P. Lollini, P. Picci, S. Avnet, 2002, International journal of cancer.

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis

P. Musiani, P. Lollini, R. Kennedy, 2007, International journal of cancer.

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2005, The American journal of pathology.

Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2004, Cancer Research.

Immunoprevention of Mammary Carcinoma in HER-2/neu Transgenic Mice Is IFN-γ and B Cell Dependent1

P. Musiani, P. Lollini, G. Forni, 2004, The Journal of Immunology.

Immunoprevention of colorectal cancer: a future possibility?

P. Musiani, P. Lollini, G. Forni, 2002, Gastroenterology clinics of North America.

Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.

P. Lollini, N. Baldini, K. Scotlandi, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Inhibition of Lung Colonisation of a Mouse Mammary Carcinoma by Therapeutic Vaccination with Interferon-α Gene-Transduced Tumor Cells

Flavia Frabetti, Filippo Belardelli, Piero Musiani, 1998, Clinical & Experimental Metastasis.

Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.

P. Lollini, P. Nanni, C. De Giovanni, 1992, British Journal of Cancer.

Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor

P. Lollini, M. Iezzi, P. Nanni, 2012, PloS one.

Minor histocompatibility antigens do not enhance BALB/c anti-SV40 TASA response.

P. Lollini, S. Grilli, P. Nanni, 1981, British Journal of Cancer.

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

Piero Musiani, Federica Cavallo, Manuela Iezzi, 2004, Cancer research.

A Limited Autoimmunity to p185neu Elicited by DNA and Allogeneic Cell Vaccine Hampers the Progression of Preneoplastic Lesions in HER-2/NEU Transgenic Mice

P. Musiani, P. Lollini, G. Forni, 2005, International journal of immunopathology and pharmacology.

Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells.

P. Lollini, K. Scotlandi, P. Nanni, 1991, Invasion & metastasis.

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

P. Musiani, P. Lollini, M. Iezzi, 2009, Vaccine.

Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.

P. Lollini, E. Lalli, P. Nanni, 1992, British Journal of Cancer.

Induction of invasive and experimental metastasis potential in BALB/c 3T3 cells by benzo(a)pyrene transformation.

S. Parodi, A. Colacci, P. Lollini, 1992, Invasion & metastasis.

Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

P. Lollini, P. Nanni, C. De Giovanni, 2009, Proceedings of the National Academy of Sciences.

Establishment and characterization of multidrug-resistant human osteosarcoma cell lines.

P. Lollini, D. Maurici, N. Baldini, 1993, Anticancer research.

Are colony-stimulating factor-producing cells facilitated in the metastatic process?

P. Lollini, P. Nanni, C. De Giovanni, 1987, Anticancer research.

Apc10.1: An ApcMin/+ intestinal cell line with retention of heterozygosity

P. Lollini, P. Nanni, C. De Giovanni, 2004, International journal of cancer.

Expression of transduced carcinoembryonic antigen gene in human rhabdomyosarcoma inhibits metastasis.

P. Lollini, A. Santoni, P. Nanni, 1996, Cancer research.

An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma.

P. Lollini, P. Nanni, C. De Giovanni, 2001, European journal of cancer.

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R

P. Lollini, A. Amici, P. Nanni, 2019, Cancers.

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

P. Lollini, P. Nanni, C. De Giovanni, 2019, BMC Cancer.

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

P. Lollini, P. Nanni, C. De Giovanni, 2011, Vaccine.

Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.

P. Lollini, G. Forni, A. Modica, 1995, Human gene therapy.

Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent.

P. Musiani, P. Lollini, G. Forni, 2004, Journal of immunology.

Vaccines and other immunological approaches for cancer immunoprevention.

Federica Cavallo, Patrizia Nanni, Guido Forni, 2011, Current drug targets.

Interferon-mediated modulation of metastasis and MHC antigens.

P. Lollini, K. Scotlandi, P. Nanni, 1988, Advances in experimental medicine and biology.

Alterations in folate-dependent one-carbon metabolism as colon cell transition from normal to cancerous.

D. Conti, D. Chui, C. De Giovanni, 2019, The Journal of nutritional biochemistry.

17β-estradiol, 5α-Dihydrotestosterone, Progesterone and Cortisol Receptors in Normal and Neoplastic Human Endometrium 1

S. Grilli, C. De Giovanni, G. Prodi, 1979, Tumori.

Is mts1 (S100A4) Gene Involved in the Metastatic Process Modulated by Gamma-Interferon?

P. Lollini, C. De Giovanni, R. Chiaramonte, 1998, Pathobiology.

Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment.

P. Lollini, V. Giorgio, A. Porcelli, 2014, Human molecular genetics.

Oncolytic herpes virus retargeted to HER-2

P. Lollini, P. Nanni, C. De Giovanni, 2009, Cell cycle.